Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

Bas W.G. van Rhijn(The Netherlands Cancer Institute), Theodorus van der Kwast(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Geert J.L.H. van Leenders(Erasmus MC Cancer Institute), André N. Vis(Hôpitaux Universitaires Henri-Mondor), François Radvanyi(Centre National de la Recherche Scientifique), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor), Adriaan C. Jöbsis(Hôpitaux Universitaires Henri-Mondor), Gina Lockwood(University Health Network), Bert C.M. Ooms(GGD Haaglanden), Wim J. Kirkels(Erasmus MC), Tahlita C.M. Zuiverloon(Erasmus MC)
European Urology
June 10, 2010
10.1016/j.eururo.2010.05.043
Cited by 193

Related Papers

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
|European Urology|2015|639
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
|Journal of Clinical Oncology|2008|597